Profile

Dr. Marco Davila is a medical oncologist who specializes in the treatment of patients with cancer. Dr. Davila has a particular interest in patients with hematologic malignancies such as chronic lymphocytic leukemia (CLL), B cell Acute Lymphoblastic Leukemia (B-ALL), and Acute Myeloid Leukemia (AML).Read more...

Dr. Marco Davila is a medical oncologist who specializes in the treatment of patients with cancer. Dr. Davila has a particular interest in patients with hematologic malignancies such as chronic lymphocytic leukemia (CLL), B cell Acute Lymphoblastic Leukemia (B-ALL), and Acute Myeloid Leukemia (AML). As a translational physician-scientist, he is engaged in both clinical and laboratory research involving these malignancies. Dr. Davila's laboratory develops gene-engineered cell therapies that target cancer cells in animal models of hematologic malignancies. The goal of this laboratory research is to identify optimal cell therapies that can then be evaluated in patients with cancer. As a former Principal Investigator of a clinical trial using genetically engineered T cells targeted against malignant B cells, he witnessed the potential for this as a cancer immunotherapy. It's Dr. Davila's hope that his innovative laboratory and clinical research here at Vanderbilt will lead to similar therapeutic options for patients with other cancers that are not responsive to standard chemotherapy.